S Korea: Samsung Biologics begins production of Moderna COVID-19 vaccine

Oct 14, 2021

Seoul [South Korea], October 14 (ANI/Global Economic): Samsung Biologics has begun production of Moderna COVID-19 vaccine and secured supplies before GMP approval.

Moderna's research cooperation with Korea. Will it speed up the development of mRNA vaccines?

May 25, 2021

Seoul [South Korea], May 25 (ANI/Global Economic): During the ROK-US summit, the attention is focused on whether the government will foster the development of...

Samsung Biologics to supply Moderna vaccines in earnest, to become K-bio 'vaccine hub'

Oct 27, 2021

Seoul [South Korea], October 27 (ANI/Global Economic): Moderna's COVID-19 vaccine produced by Samsung Biologics will be supplied domestically and globally, allowing Korea to solidify...

Experts speculate Samsung's spinoff of foundry business will boost trust and competitiveness, Samsung says it's too early

May 30, 2025

Samsung Electronics is likely to spin off its foundry business from the broader semiconductor division, on the same conflict of interest that separated Samsung...

Samsung Biologics secures half of Japan's top 10 pharmas as clients

Oct 11, 2025

Samsung Biologics Co is accelerating its expansion in Japan, the world's third-largest pharmaceutical market. The South Korean company has signed contracts with half of...

Korean bio 'Big 3' Samsung, Celltrion, SK to expand their businesses in Songdo

Dec 29, 2021

Seoul [South Korea], December 29 (ANI/Global Economic): As SK Bioscience announced its plan to open a new R&PD center in Songdo, Incheon, three Korean...